title: Increased production of superoxide anion contributes to dysfunction of the arteriovenous fistula.
abstract: Vascular access dysfunction causes morbidity in hemodialysis patients. This study examined the generation and pathobiological significance of superoxide anion in a rat femoral arteriovenous fistula (AVF). One week after AVF creation, there was increased production of superoxide anion accompanied by decreased total superoxide dismutase (SOD) and Cu/Zn SOD activities and induction of the redox-sensitive gene heme oxygenase-1. Immunohistochemical studies of nitrotyrosine formation demonstrated that peroxynitrite, a product of superoxide anion and nitric oxide, was present in increased amounts in endothelial and smooth muscle cells in the AVF. Because uncoupled NOS isoforms generate superoxide anion, and NOS coupling requires tetrahydrobiopterin (BH(4)) as a cofactor, we assessed NOS uncoupling by determining the ratio of BH(4) to dihydrobiopterin (BH(2)); the BH(4)-to-BH(2) ratio was markedly attenuated in the AVF. Because Src is a vasculopathic signaling species upstream and downstream of superoxide anion, such expression was evaluated; expression of Src and phosphorylated Src was both markedly increased in the AVF. Expression of NADPH oxidase (NOX) 1, NOX2, NOX4, cyclooxygenase (COX) 1, COX2, p47(phox), and p67(phox) was all unchanged, as assessed by Western analyses, thereby suggesting that these proteins may not be involved in increased production of superoxide anion. Finally, administration of tempol, a superoxide anion scavenger, decreased neointima formation in the juxta-anastomotic venous segment and improved AVF blood flow. We conclude that the AVF exhibits increased superoxide anion generation that may reflect the combined effects of decreased scavenging by SOD and increased generation by uncoupled NOS, and that enhanced superoxide anion production promotes juxta-anastomotic stenosis and impairs AVF function.
authors.forename: Mykola V
authors.initials: MV
authors.lastname: Tsapenko
authors.forename: Livius V
authors.initials: LV
authors.lastname: d'Uscio
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Grande
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Croatt
authors.forename: Melissa C
authors.initials: MC
authors.lastname: Hernandez
authors.forename: Allan W
authors.initials: AW
authors.lastname: Ackerman
authors.forename: Zvonimir S
authors.initials: ZS
authors.lastname: Katusic
authors.forename: Karl A
authors.initials: KA
authors.lastname: Nath
mesh_terms: D000818:Animals; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects*; D001708:Biopterins / Q000031:analogs & derivatives / Q000378:metabolism; D005268:Femoral Vein / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D005269:Femur / Q000098:blood supply* / Q000601:surgery; D023421:Models, Animal; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction; D013481:Superoxides / Q000378:metabolism*; D019061:src-Family Kinases / Q000378:metabolism
chemical_list: D013481:Superoxides; D001708:Biopterins; C017226:7,8-dihydrobiopterin; D019061:src-Family Kinases; C003402:sapropterin